Neoadjuvant camrelizumab plus trastuzumab and chemotherapy for HER2-positive gastric or gastroesophageal junction adenocarcinoma: a single-arm, phase 2 trial
新辅助卡瑞利珠单抗联合曲妥珠单抗和化疗治疗HER2阳性胃癌或胃食管交界处腺癌:一项单臂II期试验
期刊:Gastric Cancer
影响因子:5.1
doi:10.1007/s10120-025-01606-w
Ma, Yijie; Li, Zhi; Wei, Chen; Zhang, Jian; Fu, Qiang; Zhang, Zhandong; Shang, Chuang; Wang, Jinbang; Wan, Xiangbin; Zhang, Bin; Zhang, Yongchao; Li, Jing; Zhang, He; Bie, Liangyu; Xia, Qingxin; Luo, Suxia; Li, Ning